INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-01-03

Reporting Person: Zoth Lota S. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-03	Common Stock	M	4090	—	Acquired	16193	Direct
2021-01-05	Common Stock	S	961	$9.48	Disposed	15232	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-03	Restricted Stock Unit	$	M	4090	Disposed		Common Stock (4090.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares vested on January 3, 2020; 4,090 shares vested on January 3, 2021; 4,090 shares will vest on January 3, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.